Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a small update to the page's revision tag.
    Difference
    0.1%
    Check dated 2026-05-15T05:46:45.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a minor version change to the site display rather than a change to the clinical trial content.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:15.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:16.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Medullary thyroid carcinoma is now listed as a condition, and the Genetic and Rare Diseases Information Center has been added to the Resources section.
    Difference
    0.2%
    Check dated 2026-04-02T15:14:42.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:43:47.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is shown instead of v3.4.2. There are no visible changes to the study information or user actions on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:38.000Z thumbnail image

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.